ABSTRACT
S79 Figure 1ConclusionAmong patients with COPD in routine clinical practice in England, the frequency of moderate and severe exacerbations declined between January 2020 and April 2020 for most stratification groups and remained low through to August 2020. When comparing GOLD grade at baseline, the proportion of patients to experience an exacerbation increased with increasing disease severity grade.Please refer to page A211 for declarations of interest related to this abstract.
ABSTRACT
S75 Figure 1ConclusionAmong patients with asthma, the frequency of severe exacerbations declined steeply between March 2020 and May 2020 for all stratification groups and remained low through to August 2020. When comparing GINA step at baseline, a higher proportion of patients in GINA steps 4 and step 5 experienced a severe exacerbation compared with patients in GINA steps 1/2, step 2 and step 3 throughout the observation period. Further research on the long-term impact of COVID-19 on asthma exacerbations in routine clinical practice in England is warranted.Please refer to page A211 for declarations of interest related to this .
ABSTRACT
S39 Figure 1ConclusionAmong patients with asthma, COVID-19 diagnosis rates peaked in April 2020, declined steeply to June 2020 and remained low through to August 2020. COVID-19 hospitalisation rates were substantially higher in patients with more severe asthma and highest among patients in GINA step 5 treatment group. Future studies on the long-term impact of COVID-19 in asthma are warranted.Please refer to page A209 for declarations of interest related to this .